ALT vs HAL · rev $20.0K vs P/E 9.3, $19.05B cap
Altimmune Inc (ALT) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
HAL does not have a complete income-statement cache yet.
ALT currently screens at market cap $527.0M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the ALT and HAL stock pages for the full models.
Not investment advice.